The European Medicines Agency (EMA) has re-evaluated the Alzheimer's drug lecanemab and decided to authorize the product. The decision comes…
BBVA seeks permission to launch takeover bid for SabadellHumberto Bilbao BBVA has already sent a request for permission of the…